Topic outline

• 

  Novo Nordisk ®

  

  
  

  
  
  
  
  
  

  Unrestricted educational grant for the development of the following activities:
  Growth Hormone Deficiency: An interactive Debate about Diagnosis, Dosage, and Treatment.
  Ask the Experts: What is the role of GLP-1 RAs in the current landscape of incretin therapies  for T2D
  Transitioning hypopituitary patients from childhood to adulthood: what do endocrinologists need to know?
  Spotlight on Safety: How can long-term GH therapy risks be mitigated?
• 

  MDBriefCase TM/MC

  
  
  
  
  
  

  Unrestricted educational grant for the development of the following activities:
  Knowledge Transfer Series (KTS)
  Webinar: International Experts Explore and Debate New Developments in Diabetes
• 

  Thermo Fisher Scientific

  

  
  

  
  

  Unrestricted educational grant for the development of the following activities:
  Diabetes Insipidus - From Differential Diagnosis to Post-operative DI
  Highly sensitive thyroglobulin and anti-thyroglobulin antibody measurement in DTC management
• 

  Pfizer Inc.

  

  
  

  
  

  
  
  

  Unrestricted educational grant for the development of the following activity:
  What is the place of long-acting GH in the management of pediatric and adult patients?

  
  
• 

  Ascendis Pharma

  

  
  

  
  

  
  
  

  Unrestricted educational grant for the development of the following activity:
  GHD Diagnosis and Management in Adults: Who to test and how to treat?